At this time, I would like to welcome everyone to the Pulse Biosciences’ Fourth Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the ...
Abbott Laboratories snagged a CE mark for its Volt pulsed field ablation catheter for atrial fibrillation several months earlier than the mid-year approval expected. The Abbott Park, Ill.-based ...
A group of 29 international experts says that simultaneous screening for hypertension and heart arrhythmia could prevent ...
Abbott is joining the worldwide race to make pulsed field ablation the standard procedure for atrial fibrillation with an ...
The company is first rolling out the use of the Volt system among European Union doctors who have already gained experience ...
Though late to the party compared to other industry mammoths, Abbott joins a pulsed field ablation market poised for ...
The Volt PFA system. [Image courtesy of Abbott] Abbott (NYSE: ABT) + announced it received CE mark approval in Europe for its ...
Abbott's Volt PFA System is designed to provide a new therapy option for people battling heart rhythm disorders such as atrial fibrillationPulsed field ablation - or PFA - uses high energy electrical ...
Thursday announced it has received CE Mark in Europe for the Volt PFA System to treat patients battling atrial fibrillation (AFib).
St. David's in Austin is the first in country to use new dual catheter to fix heart flutter and AFib at the same time.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results